tiprankstipranks
Trending News
More News >
Protagonist Therapeutics Inc (PTGX)
NASDAQ:PTGX
US Market

Protagonist Therapeutics (PTGX) Ratios

Compare
734 Followers

Protagonist Therapeutics Ratios

PTGX's free cash flow for Q4 2025 was $0.95. For the 2025 fiscal year, PTGX's free cash flow was decreased by $ and operating cash flow was $-5.88. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
12.71 12.71 12.48 16.71 7.80
Quick Ratio
12.71 12.71 12.48 16.71 7.80
Cash Ratio
2.83 2.83 2.05 8.78 4.03
Solvency Ratio
-2.34 -2.34 3.98 -3.56 -3.84
Operating Cash Flow Ratio
1.27 1.27 3.89 -3.30 -3.47
Short-Term Operating Cash Flow Coverage
25.26 25.26 0.00 0.00 0.00
Net Current Asset Value
$ 522.39M$ 522.39M$ 522.21M$ 334.30M$ 210.76M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.02 0.01 <0.01 0.01
Debt-to-Equity Ratio
0.02 0.02 0.02 <0.01 0.02
Debt-to-Capital Ratio
0.02 0.02 0.02 <0.01 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.09 1.09 1.10 1.06 1.15
Debt Service Coverage Ratio
-63.06 -56.47 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
0.16 0.16 0.18 0.02 0.07
Net Debt to EBITDA
0.82 0.92 -0.34 2.05 0.95
Profitability Margins
Gross Profit Margin
99.18%97.34%100.00%100.00%100.00%
EBIT Margin
-313.82%-281.01%58.20%-156.09%-494.24%
EBITDA Margin
-311.04%-278.35%58.39%-150.57%-481.56%
Operating Profit Margin
-343.63%-343.63%58.20%-156.09%-494.24%
Pretax Profit Margin
-281.01%-281.01%64.32%-131.59%-479.26%
Net Profit Margin
-282.83%-282.83%63.34%-131.59%-479.26%
Continuous Operations Profit Margin
-282.83%-282.83%63.34%-131.59%-479.26%
Net Income Per EBT
100.65%100.65%98.49%100.00%100.00%
EBT Per EBIT
81.78%81.78%110.51%84.31%96.97%
Return on Assets (ROA)
-19.43%-19.43%36.95%-22.06%-51.38%
Return on Equity (ROE)
-19.89%-21.17%40.75%-23.45%-59.09%
Return on Capital Employed (ROCE)
-25.32%-25.32%36.26%-27.82%-60.61%
Return on Invested Capital (ROIC)
-25.23%-25.23%35.69%-27.72%-59.92%
Return on Tangible Assets
-19.43%-19.43%36.95%-22.06%-51.38%
Earnings Yield
-2.05%-2.34%11.58%-6.07%-23.81%
Efficiency Ratios
Receivables Turnover
10.23 10.23 2.58 5.81 511.17
Payables Turnover
0.07 0.23 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
3.94 3.94 34.46 27.92 5.75
Asset Turnover
0.07 0.07 0.58 0.17 0.11
Working Capital Turnover Ratio
0.09 0.09 0.99 0.22 0.10
Cash Conversion Cycle
-5.15K -1.56K 141.56 62.85 0.71
Days of Sales Outstanding
35.66 35.66 141.56 62.85 0.71
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
5.18K 1.59K 0.00 0.00 0.00
Operating Cycle
35.66 35.66 141.56 62.85 0.71
Cash Flow Ratios
Operating Cash Flow Per Share
0.91 0.91 2.99 -1.24 -2.20
Free Cash Flow Per Share
0.91 0.88 2.97 -1.25 -2.22
CapEx Per Share
0.00 0.03 0.02 0.01 0.02
Free Cash Flow to Operating Cash Flow
1.00 0.97 0.99 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
0.00 36.27 135.91 -115.33 -136.02
Capital Expenditure Coverage Ratio
0.00 36.27 135.91 -115.33 -136.02
Operating Cash Flow Coverage Ratio
5.59 5.59 16.95 -61.56 -29.58
Operating Cash Flow to Sales Ratio
1.25 1.25 0.42 -1.17 -4.07
Free Cash Flow Yield
0.90%1.01%7.69%-5.44%-20.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-49.67 -42.66 8.64 -16.49 -4.20
Price-to-Sales (P/S) Ratio
141.00 120.66 5.47 21.69 20.13
Price-to-Book (P/B) Ratio
10.52 9.03 3.52 3.87 2.48
Price-to-Free Cash Flow (P/FCF) Ratio
112.50 99.01 13.00 -18.37 -4.91
Price-to-Operating Cash Flow Ratio
112.09 96.28 12.91 -18.53 -4.95
Price-to-Earnings Growth (PEG) Ratio
0.13 0.29 -0.02 0.37 0.86
Price-to-Fair Value
10.52 9.03 3.52 3.87 2.48
Enterprise Value Multiple
-44.51 -42.43 9.03 -12.35 -3.23
Enterprise Value
6.26B 5.43B 2.29B 1.12B 412.96M
EV to EBITDA
-43.76 -42.43 9.03 -12.35 -3.23
EV to Sales
136.11 118.10 5.27 18.60 15.54
EV to Free Cash Flow
108.60 96.90 12.53 -15.75 -3.79
EV to Operating Cash Flow
108.60 94.23 12.44 -15.89 -3.82
Tangible Book Value Per Share
9.67 9.67 10.97 5.93 4.40
Shareholders’ Equity Per Share
9.67 9.67 10.97 5.93 4.40
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 0.02 0.00 0.00
Revenue Per Share
0.72 0.72 7.06 1.06 0.54
Net Income Per Share
-2.05 -2.05 4.47 -1.39 -2.60
Tax Burden
1.01 1.01 0.98 1.00 1.00
Interest Burden
0.90 1.00 1.11 0.84 0.97
Research & Development to Revenue
3.46 3.46 0.32 2.00 4.75
SG&A to Revenue
0.73 0.97 0.10 0.56 1.19
Stock-Based Compensation to Revenue
0.77 1.00 0.09 0.49 0.91
Income Quality
0.00 0.00 0.67 0.89 0.85
Currency in USD